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‘When a variation in characteristic is of the slightest use to
a being, we cannot tell how much to attribute to natural




Coronary heart disease (CHD), hypertension, and diabetes
mellitus (DM) occur in epidemic proportions worldwide.
Unhealthy lifestyle practices and behaviours are well accepted
as contributing factors, but the true origins of these diseases
may actually be found in utero. According to the Barker
hypothesis, disturbed intrauterine growth has a negative
influence on the development of the cardiovascular system and
favours the occurrence of hypertension, insulin resistance,
hypercholesterolaemia, and hyperuricaemia in adult life.1
Many chronic disorders that manifest later in life may be
related to two seemingly opposing factors potentially present
early in life: (i) poverty, i.e. malnourished mothers give birth to
malnourished infants with low birth weight (LBW); and (ii)
prosperity, i.e. exposure of an infant with LBW phenotype to a
high-energy (caloric) diet. These factors contribute to the
biological phenomenon of developmental plasticity, or the
ability of a genotype to produce multiple forms and behaviours
in response to environmental conditioning.
Living things are often plastic during early development,
and consequently can be moulded by the environment. By
adapting to a limited supply of nutrients, it appears that the
human fetus trades off the development of non-essential
organs, such as kidney (nephron mass) and pancreas (beta cell
mass), in favour of more essential organs such as the brain.
These developmental adaptations may be the origins of a
number of diseases in later life2 and are thought to be
consequences of fetal programming, whereby adaptations
invoked in response to deficient maternal-placental nutrient
supply have permanent effects on structure, physiology, and
metabolism.3
Inverse relationship between birth
weight and disease
The combination of LBW and small size during infancy,
followed by accelerated weight gain from age 3 - 11 years, is
predictive of hypertension, CHD, and type 2 DM, according to
Professor D J P Barker, of the Medical Research Council,
Southampton General Hospital, UK. In his address at the 9th
Asian Pacific Congress of Nephrology,4 Barker discussed his
research findings showing the delayed effects, especially on
heart disease, of the early developmental environment. On the
basis of these and related studies, Barker contends that optimal
nutrition is crucial during fetal development and throughout
infancy.5
In support of the Barker hypothesis, numerous studies
(reviewed by Phenekos6) have unequivocally shown an inverse
relationship between the birth weight of infants born preterm
or at term and the increased incidence of hypertension, CHD,
impaired glucose tolerance, insulin resistance, and type 2 DM.
These associations have been extensively replicated in studies
conducted in a number of countries and do not appear to be
the result of confounding variables.3
Relationship between birth weight,
glomerular mass, and chronic kidney
disease
LBW has been hypothesised to affect normal renal
development adversely, thereby contributing to an increased
risk of acute renal failure and transient imbalance of fluid and
electrolyte homeostasis soon after birth7 and an increased risk
of developing chronic kidney disease later in life.8,9 Although
the number of nephrons in the human kidney varies
considerably under normal circumstances, retarded
intrauterine growth has been reported to be associated
specifically with a significant reduction in nephron numbers. In
turn, low nephron numbers may be an independent risk factor
for the development of hypertension.
Manalich and colleagues10 evaluated the relationship
between birth weight and the number of glomeruli and
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glomerular volume by examining coronal sections of the
kidneys of 35 neonates who died within 2 weeks of birth as a
result of hyaline membrane disease, infectious complications,
brain haemorrhage, or perinatal hypoxia. There were
significant differences in the number of glomeruli (p < 0.0001)
and glomerular volume (p < 0.0001) between the LBW and
normal birth weight (NBW) groups. Essential arterial
hypertension was present in 38.9% of the mothers of LBW
children v. 5.9% of the mothers of NBW children (p < 0.05). It
appears therefore that endowment with decreased nephron
mass may be a risk factor for hypertension and the rate of
progression of renal disease.
In contrast, the findings of Nyengaard and colleagues11 did
not support associations between LBW and low kidney weight
or between LBW and a decrease in number and/or small
glomeruli in patients with type 2 DM. To determine whether
there was a correlation between LBW and the development of
type 2 DM and high blood pressure, Nyengaard and colleagues
examined 79 autopsy kidneys (with known weight) from
normal and type 2 DM patients, which had previously been
used for studies of glomerular number and volume. There
were no significant correlations between birth weight and
glomerular number, glomerular volume, or kidney weight.
Relationship between birth weight and
blood pressure
Hypertension may originate from retarded growth in utero,
followed by accelerated postnatal growth. Retarded fetal
growth leads to permanently reduced cell numbers in the
kidney and other tissues, and subsequent accelerated growth
may lead to excessive metabolic demand on this limited cell
mass.
To determine whether diminished number of nephrons is a
factor contributing to the development of primary
hypertension, Keller and colleagues12 compared the number
and volume of glomeruli in 10 middle-aged white patients
with a history of primary hypertension, left ventricular
hypertrophy, or both, and renal arteriolar lesions with the
number and volume of glomeruli in 10 normotensive subjects.
Hypertensive patients had significantly fewer glomeruli per
kidney and significantly greater glomerular volume than
matched normotensive controls (p < 0.001). These data
demonstrate that the number of nephrons is reduced among
white patients with primary hypertension.
Law and colleagues13 were among the first to assess the
association between blood pressure (BP) and LBW and to
determine whether a relationship was established in utero or
during infancy, and if it changed over time. The study included
1 895 children aged 0 - 10 years, 3 240 men and women aged 
36 - 40 years, 459 men and women aged 46 - 54 years, and 1 231
men and women aged 59 - 71 years. All participants had a
recorded birth weight. Increased systolic blood pressure (SBP)
was found in all groups beyond infancy among participants
with LBW compared with NBW individuals. The relationship
became more pronounced with increasing age; SBP at age
64 - 71 years decreased by 5.2 mmHg (95% confidence interval
(CI): 1.8 - 8.6) for every kilogram increase in birth weight after
allowing for current body mass. The researchers concluded that
essential hypertension was established during the fetal period
and amplified over time.
A number of subsequent studies have examined the
relationship between birth weight and BP during adolescence.
In a retrospective study, 330 participants who were LBW at
term delivery were matched with controls of NBW.14 The mean
SBP was not significantly different between groups: 105.8
mmHg for the LBW individuals v. 107.5 mmHg for the NBW
controls. Nilsson and colleagues15 prospectively studied the
association between birth weight and BP in 18-year-old males.
Weight, height, and mean BP were measured and stratified
according to birth weight. SBP, but not diastolic blood pressure
(DBP), differed significantly (p < 0.001) between birth weight
strata; SBP was higher in the LBW strata. An increase in birth
weight of 1 000 g decreased SBP by 0.8 mmHg, and was most
pronounced in participants who had experienced rapid growth
and development. The investigators concluded that LBW was
inversely associated with SBP, supporting the concept of an in
utero programming effect of fetal growth retardation on
haemodynamics in early adult life.
In a study of 165 136 Swedish men aged 18 years, SBP was
independently and inversely associated with both gestational
age and birth weight for gestational age.16 The difference in SBP
between the top and bottom quintiles of birth weight for
gestational age was –1.61 mmHg (95% CI: –1.82 - –1.40) after
adjustment for birth length for gestational age, height, and
weight. A similar study demonstrated that BP was significantly
higher in late adolescence among individuals born preterm at
very low birth weight (VLBW) (birth weight ≤ 1 500 g)
compared with NBW controls. In a cohort study, Doyle and
colleagues17 compared BP between VLBW preterm survivors 
(N = 156) and randomly selected NBW subjects (N = 38) at age
≥ 18 years. BP was assessed using both a standard mercury
sphygmomanometer and an ambulatory BP monitor. Higher
SBP and DBP (as measured by sphygmomanometer) were
observed in the VLBW group compared with the NBW group
(mean difference (95% CI):  SBP 8.6 mmHg (3.4 - 13.9); DBP
4.3 mmHg (1.0 - 7.6)). Although there was no difference
between the groups with regard to ambulatory DBP, the VLBW
group had significantly higher mean SBP compared with
controls (mean difference (95% CI) for the 24-hour period: 4.7
mmHg (1.4 - 8.0)). Differences persisted during periods of
waking and sleeping.
A longitudinal study conducted by Law and colleagues18
assessed BP at age 22 years among 346 participants (males and
females) who were measured at birth, then yearly for the first
10 years of life. Individuals who were small at birth but gained
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weight rapidly between 1 and 5 years of age had the highest
BP at age 22. Again, the most significant effect observed was in
SBP, which increased by 1.3 mmHg (95% CI: 0.3 - 2.3) for every
standard deviation decrease in birth weight. SBP also increased
independently by 1.6 mmHg (95% CI: 0.6 - 2.7) for every
standard deviation increase in weight gain during age 1 - 5
years. Relationships were less significant for DBP. Although
adjustment for adult body mass attenuated the effect of rapid
weight gain during early childhood (age 2 - 5 years), it did not
influence the relationship between birth weight and BP. On the
basis of these data, the authors concluded that even though a
significant risk for adult hypertension is established during
fetal development, accelerated weight gain during early
childhood also contributes to the burden of risk.
Relationship between birth body
length and BP
In addition to finding a negative association between birth
weight and SBP at age 20 in men and women, research by
Moore and colleagues19 also demonstrated that decreased body
length and thinness at birth and LBW relative to placental
weight were associated with elevated SBP in later life. BP
effects were greatest among individuals with increased weight
or excess weight for height at age 20 years. The effects of birth
weight on BP were more pronounced at age 20 years than at
age 8 years (p < 0.01 for men and p = 0.03 for women).
A prospective study20 from Sweden supported the hypothesis
that poor fetal growth, as measured by LBW or decreased body
length at birth, may contribute to the development of
hypertension in later life, and that these associations increase
with age. BP was assessed at age 50 years and at 60 years in
438 women born at term. There was a significantly higher risk
of hypertension in the lowest birth weight quintile (odds ratio
(OR) 2.0, 95% CI: 1.1 - 3.8) and lowest birth length tertile (OR
1.8, 95% CI: 1.1 - 3.0) compared with the middle quintile and
tertile, with or without adjustment for adult body size (as
measured by body mass index (BMI)) at age 60 years. At 60
years of age hypertension risk decreased by 4% (95% CI: 0.92 -
0.99) per 100 g birth weight and 10% (95% CI: 0.81 - 0.99) per
cm body length. No significant increased risk was observed in
the 50-year-old age group.
Relationship between birth weight and
coronary heart disease
There is emerging evidence from experimental and clinical
studies of a link between LBW and cardiovascular disease in
adulthood.21 Barker22 hypothesised that individuals who
develop CHD experience slowed growth during fetal life and
infancy, followed by accelerated weight gain in childhood.
Hypertension and type 2 DM, disorders that predispose to the
development of CHD, have been linked to similar paths of
growth. Specific underlying mechanisms for CHD may include
reduced number of nephrons associated with LBW, the
development of insulin resistance in utero, and altered
programming of the microarchitecture and function of the liver.
A longitudinal study23 conducted in Finland assessed the
associations between birth size, growth during infancy and
childhood, and risk for CHD, using the outcome measure of
hospitalisation for or death from cardiac disease. Data from 
4 630 males born between 1934 and 1944 who attended child
welfare clinics were analysed. Individuals in the data set had
an average of 18 measures of weight and height recorded
between birth and age 12 years. Low weight and decreased
height at birth and at age 1 year were associated with an
increased risk of heart disease. Rapid weight gain and an
increased BMI after age 1 year also increased the risk of CHD,
but this increase was confined to those who were thin at birth.
The adverse effects of rapid weight gain were apparent by 3
years of age in this cohort.
Relationship between birth weight and
diabetes mellitus
A number of studies conducted during the past decade have
established a relationship between suboptimal fetal and infant
growth and the development of metabolic syndrome and type
2 DM. It is believed that poor nutrition in early life results in
permanent changes in glucose-insulin metabolism, leading to a
decreased capacity for insulin secretion and insulin resistance.
Although the strength of this association has varied among
studies, the link between early growth and insulin resistance
has been documented in all age groups.
Forsen and colleagues24 determined that type 2 DM is
programmed in utero in association with low rates of fetal
growth. In a large cohort study, they examined the relationship
between type 2 DM and size at birth and childhood growth in
men (N = 3 639) and women (N = 3 447) born in Helsinki,
Finland, between 1924 and 1933, who still lived in Finland in
1971, and for whom detailed birth and school health records
were available. The prevalence of DM (7.9%) was ascertained
from a national register. The main predictors were size at birth
and childhood growth in terms of height, weight, and BMI.
The incidence of DM increased with decreasing birth weight,
birth body length, ponderal index (birth weight/body length),
and placental weight. The OR for development of type 2 DM
was 1.38 (95% CI: 1.15 - 1.66, p < 0.001) for each 1 kg decrease
in birth weight. The OR for development of type 2 DM was
1.39 (95% CI: 1.21 - 1.61, p < 0.001) for each standard deviation
increase in weight between 7 and 15 years of age. Children
whose mothers had a high BMI during pregnancy had more
rapid growth during childhood and an increased incidence of
type 2 DM.
In a recent study,25 LBW and high birth weight (HBW) were
associated with an increased risk of type 2 DM in children. All
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children in Taiwan Province aged 6 - 18 years were assessed for
the presence of DM over a 5-year period; 429 children with
type 2 DM and 549 with a normal fasting blood glucose level
were included in the analyses. After adjusting for the variables
of family history, socioeconomic status, age, sex, and BMI, the
ORs for development of type 2 DM were 2.91 (1.25 - 6.76) for
children with LBW (< 2 500 g) and 1.78 (1.04 - 3.06) for children
with HBW (≥ 4 000 g), compared with the control group (birth
weight 3 000 - 3 499 g).
Conclusion
A strong case has been made for the delayed effects of
suboptimal fetal development. More data supporting the
Barker hypothesis are continuing to emerge. However,
alternative interpretations of these findings include socio-
economic conditions present at birth that tend to persist
throughout the lifespan, and the prevailing conditions of
childhood that have greater influence on adult health than
adverse conditions during fetal life and early infancy.
Additional studies will further help to define the relative
contributions of birth weight, weight change, and the
environment in which a child develops to adulthood with
chronic, adult-onset disease.
Republished with permission from Medscape Transplantation
(http://www.medscape.com/viewarticle/453242), 2003, WedMD,
Inc. The Medscape publication was a conference report,
‘Intrauterine Growth and Disease in Later Life’ — highlights from
the 9th Asian Pacific Congress of Nephrology, Pattaya, Thailand, 16
- 20 February 2003 (Medscape Transplantation 2003; 5(1)), posted 5
July 2003.
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